Novigenix ^Company

Novigenix is a Swiss precision medicine company that specializes in ImmunoTranscriptomic solutions for disease detection, therapy optimization, and disease recurrence monitoring. Their proprietary LITOseek platform integrates patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches to provide actionable insights and precision solutions for optimization of patient\u2019s therapeutic journey. Novigenix's product pipeline includes patient stratification solutions in the field of Immuno-Oncology, Colorectal Cancer early detection and recurrence monitoring, and therapy optimization solutions for management of cancer patients. They provide services to Pharma and Biotech customers by leveraging their proprietary LITOseek data analytics and patient clinical data platform to deliver previously unknown insights into the immune system and develop ImmunoTranscriptomic solutions with actionable biomarkers for optimization of new therapeutic modalities.